Vaccines, Blood & Biologics
-
Hizentra
STN: BL 125350
Proper Name: Immune Globulin Subcutaneous (Human), 20% Liquid
Tradename: Hizentra
Manufacturer: CSL Behring AG, License #1766
Indication: Treatment of Primary Immunodeficiency (PI)
-
Supporting Documents
October 3, 2011 Approval Letter - Hizentra
To include efficacy and safety data from European Study ZLB06_001CR into the package insert.February 17, 2011 Approval Letter - Hizentra
To include revised labeling to fulfill the required pediatric assessments.Summary Basis for Regulatory Action - Hizentra , September 26, 2011 (PDF - 55KB)March 4, 2010 Approval Letter - Hizentra Summary Basis for Regulatory Action - Hizentra, March 1, 2010 (PDF - 250KB)Approval History, Letters, Reviews, and Related Documents - Hizentra
-
-
-
